Showing results (21-30 of 769) with videos related to
Sort By:
Pageof 77
The Journal of Antimicrobial Chemotherapy|January 1, 1983
Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.The Journal of Antimicrobial Chemotherapy|August 1, 1986
The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acidA King, K Shannon, J Slegg, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1983
Reduced sensitivity to beta-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infectionsA King, K Shannon, S Eykyn, et al.Antimicrobial Agents and Chemotherapy|August 1, 1980
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamasesK Shannon, A King, C Warren, et al.The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibioticsI Phillips, C Warren, K Shannon, et al.Antimicrobial Agents and Chemotherapy|November 1, 1995
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coliP Stapleton, P J Wu, A King, et al.Infection Control : IC|November 1, 1983
Environmental factors contributing to antibiotic resistanceI PhillipsLancet (London, England)|September 25, 1976
Beta-lactamase-producing, penicillin-resistant gonococcusI PhillipsClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 1998
Lessons from the past: a personal viewI PhillipsDrugs|January 1, 1987
Role of cephalosporins in gonorrhoea and other sexually transmitted diseasesI PhillipsPageof 77